Fox Run Management L.L.C. Makes New $470,000 Investment in Agilent Technologies, Inc. (NYSE:A)

Fox Run Management L.L.C. acquired a new stake in Agilent Technologies, Inc. (NYSE:A) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 3,495 shares of the medical research company’s stock, valued at approximately $470,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Madison Investment Advisors LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at $94,051,000. FMR LLC raised its position in shares of Agilent Technologies by 62.2% in the 3rd quarter. FMR LLC now owns 1,287,665 shares of the medical research company’s stock worth $191,193,000 after buying an additional 493,947 shares during the period. Raymond James Financial Inc. acquired a new position in Agilent Technologies in the fourth quarter valued at $48,172,000. Worldquant Millennium Advisors LLC purchased a new stake in Agilent Technologies during the third quarter valued at about $49,449,000. Finally, Van ECK Associates Corp increased its stake in Agilent Technologies by 8.7% during the fourth quarter. Van ECK Associates Corp now owns 3,235,263 shares of the medical research company’s stock worth $434,625,000 after acquiring an additional 258,358 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on A shares. Wells Fargo & Company decreased their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a report on Monday, December 9th. Sanford C. Bernstein decreased their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $135.00 to $145.00 in a research note on Monday, February 10th. JPMorgan Chase & Co. decreased their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. Finally, Bank of America cut their price objective on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $146.15.

Agilent Technologies Trading Down 1.3 %

Shares of A opened at $120.35 on Wednesday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. Agilent Technologies, Inc. has a one year low of $117.17 and a one year high of $155.35. The stock has a 50-day moving average price of $135.88 and a 200 day moving average price of $137.05. The company has a market capitalization of $34.31 billion, a P/E ratio of 27.67, a P/E/G ratio of 3.39 and a beta of 1.11.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.82%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s payout ratio is currently 22.76%.

Insiders Place Their Bets

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the sale, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.